Home

Publications - page 109

Search for a publication

Filter

Publication dates

Units / departments

Teams / Groups

Plateforms

Journal name

Search for a publication

8484 result(s)

2019Preclinical Studies Comparing Efficacy and Toxicity of DNA Repair Inhibitors, Olaparib, and AsiDNA, in the Treatment of Carboplatin-Resistant TumorsFrontiers in Oncology
Show authors
2019How to design a dose-finding study on combined agents: Choice of design and development of R functionsPLOS ONE
Show authors
2019Assessing reliability of intra-tumor heterogeneity estimates from single sample whole exome sequencing dataPLOS ONE
Show authors
2019STK 38 kinase acts as XPO 1 gatekeeper regulating the nuclear export of autophagy proteins and other cargoesEMBO reports
Show authors
2019Progression of deep infiltrating rectosigmoid endometriotic nodulesHuman Reproduction
Show authors
2019Fine-Needle Aspiration Features of BCOR-CCNB3 SarcomaAmerican Journal of Clinical Pathology
Show authors
2019PATTERNS OF CHORIOCAPILLARIS FLOW SIGNAL VOIDS IN CENTRAL SEROUS CHORIORETINOPATHYRetina
Show authors
2019Les peptides D-énantiomériques pourraient représenter une nouvelle piste thérapeutique dans la maladie d’Alzheimermédecine/sciences
Show authors
2019Real-space renormalization-group methods for hierarchical spin glassesJournal of Physics A: Mathematical and Theoretical
Show authors
2019A TCR-Dependent Tissue Repair Potential of MAIT CellsTrends in Immunology
Show authors
2019Time-resolved dosimetry of pulsed electron beams in very high dose-rate, FLASH irradiation for radiotherapy preclinical studiesNuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment
Show authors
2019Quand science et musique se rencontrentmédecine/sciences
Show authors
2019High-dose-rate vs. low-dose-rate interstitial brachytherapy boost for anal canal cancersBrachytherapy
Show authors
2019Dynamic Histone H3 Incorporation Fuels Metastatic ProgressionTrends in Molecular Medicine
Show authors
2019Cell-Cycle Asynchrony Generates DNA Damage at Mitotic Entry in Polyploid CellsCurrent Biology
Show authors
2019Immune gene expression in head and neck squamous cell carcinoma patientsEuropean Journal of Cancer
Show authors
2019When Can We Avoid Postmastectomy Radiation Following Primary Systemic Therapy?Current Oncology Reports
Show authors
2019Theory of antiparallel microtubule overlap stabilization by motors and diffusible crosslinkersCytoskeleton
Show authors
2019Upfront brain radiotherapy may improve survival for unfavorable prognostic breast cancer brain metastasis patients with Breast‐GPA 0‐2.0The Breast Journal
Show authors
2019Cell scientist to watch – Jean-Léon MaîtreJournal of Cell Science
2019Hyperprogressive Disease during Anti-PD-1 (PDCD1) / PD-L1 (CD274) Therapy: A Systematic Review and Meta-AnalysisCancers
Show authors
2019UCBG 2-04: Long-term results of the PACS 04 trial evaluating adjuvant epirubicin plus docetaxel in node-positive breast cancer and trastuzumab in the human epidermal growth factor receptor 2–positive subgroupEuropean Journal of Cancer
Show authors
2019Associations between sex, age and spiritual well‐being scores on the EORTC QLQ‐SWB32 for patients receiving palliative care for cancer: A further analysis of data from an international validation studyEuropean Journal of Cancer Care
Show authors
2019Towards a Cancer Mission in Horizon EuropeMolecular Oncology
Show authors
2019EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic diseaseEuropean Journal of Cancer
Show authors
2019Resistance mechanisms to osimertinib in EGFR-mutated advanced non-small-cell lung cancer: A multicentric retrospective French studyLung Cancer
Show authors
2019Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysisAnnals of Oncology
Show authors
2019Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trialThe Lancet Oncology
Show authors
2019Quantitative Proteome Landscape of the NCI-60 Cancer Cell LinesiScience
Show authors
2019Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA StudyJournal of Clinical Oncology
Show authors

Previous<

1 ...108 109 110...283

Next >